Brief: Novabay Pharmaceuticals Announces Commercial Launch Of Avenova Allograft
14/09/2023 13:21
Sept 14 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS ANNOUNCES COMMERCIAL LAUNCH OF
AVENOVA®
ALLOGRAFT
Source text for Eikon: ID:nBw53v9nRa
Further company coverage: NBY.A
((reuters.briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing